The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes.
Sesti G, Marini MA, Cardellini M, Sciacqua A, Frontoni S, Andreozzi F, Irace C, Lauro D, Gnasso A, Federici M, Perticone F, Lauro R.
Diabetes Care. 2004 Jun;27(6):1394-8.PMID: 15161794 [PubMed - indexed for MEDLINE]Related articlesFree article